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I. Introduction
Periodontitis is an inflammatory disease often
accompanied by extensive alveolar bone loss,
which surrounds the root of the teeth (Schwartz et
al., 1997). The destruction of bone in this disease is
considered to be a direct effect of pathogens or a
result of enhanced osteoclastic resorption as a con-
sequence of cytokine and prostaglandin production
by the activated inflammatory cells. Various bacteria
have been isolated from the subgingival pockets of
periodontitis patients and spirochaetes are one of
the most common bacteria in subgingival plaque
(Loesche, 1988; Kigure et al., 1995; Simonson et al.,
1988). Oral spirochetes fall into the genus
Treponema and at least 25 species have been
detected (Choi et al., 1994). However, only eight
species have been cultured so far (Moter et al.,
1998; Wyss et al., 1999; Dewirst et al., 2000).
Among these, Treponema denticola has been most
intensively studied (Fenno and McBride, 1998; Chan
and McLaughlin, 2000). In this species, the patho-
genic properties that have been identified include
adhesion (Haapasalo et al., 1996), proteolytic
enzyme production (Mäkinen et al, 1995), cytopath-
ic activity (Greiner, 1991; Mathers et al., 1996; Fenno
et al., 1998) and immunomodulation (Shenker et al.,
1984; Ding et al., 1996).
Physiological bone remodeling is controlled by a
balance between bone formation and resorption.
This balance requires the coupled activities of both
osteoblasts and osteoclasts and is controlled by a
wide variety of systemic factors including hormones,
steroids, and local factors such as prostaglandins,
cytokines and growth factors (Nair et al., 1996; Hill,
1998). Although it was reported that LPS-like materi-
als in the outer membrane of T. denticola may be
responsible for bone resorption by measuring the
release of Ca2+ from the shaft of the radii and ulnae
79
Effect of sonicates of Treponema denticola on
osteoblast differentiation
Bong-Kyu Choi1, 3, Jung-Hwa Kang1, Seung-Wook Jin1, Seung-Ho Ohk 1, 3,
Syung-IL Lee1, 2, 3, Yun-Jung Yoo1, 2
Department of Oral Biology1 and Oral Science Research Center2, College of Dentistry, Yonsei University, 
Brain Korea 21 Project for Medical Sciences3, Yonsei University
대한치주과학회지 : Vol. 33, No. 1, 2003
Correspondence and reprints: Yun- Jung Yoo, DDS, Ph.D, Dept. of Oral Biology, College of Dentistry, Yonsei University 134
Shinchon-Dong, Seodaemun-Gu, Seoul, Korea, Tel : +82-2-361-8042, Fax : +82-2-364-1085, e-mail : yu618@yumc.yonsei.ac.kr
*This project was supported by a 2002 faculty research grant from Yonsei University
of rats (Gopalsami et al., 1993) and that sonicates of
T. denticola stimulate osteoclastogenesis via
prostaglandin-dependent mechanism (Choi et al.,
1999), its effects on osteoblast differentiation are not
known. In this study, we investigated the effects of
T. denticola sonicates on the differentiation of
osteoblasts. Effect on osteoblast differentiation was
estimated by alkaline phosphatase (ALPase) activity
and formation of mineralized nodules in mouse cal-
varial cells.
II. Materials and Methods 
1. Materials
The mice (ICR strain) were obtained from Bio
Korea Co. (Seoul, Korea). α-Minimum essential
medium (α-MEM) and heat-inactivated fetal bovine
serum (FBS) were purchased from GIBCO BRL
(Grand Island, NY, USA). Ascorbic acid (AA), β-
glycerophosphate (GP), indomethacin, and ALPase
activity assay kit were obtained from Sigma (St.
Louis, MO, USA ).
2. Preparation of sonicates
T. denticola (ATCC 33521) was cultured anaerobi-
cally in an OMIZ-PAT broth for 3-5 days, as
described previously (Wyss et al., 1996). The bacter-
ial cells were harvested by centrifugation at 5,000 ×
g for 10 min at 4℃ and washed 3 times with a phos-
phate buffered saline (PBS). The bacterial cells were
then disrupted for 5 min using an ultrasonic proces-
sor (Sonic Dismembrator, Fisher Scientific, Pittsburg,
PA, USA) at an output power of 8 watts with 20 sec
intervals. The sonicates were centrifuged at 15,000
×g for 5 min at 4℃ and the supernatant was then
collected. The protein concentrations were deter-
mined by a Comassie brilliant protein assay reagent
(Pierce, IL, USA).
3. Preparation of primary calvarial cells
The osteoblastic cells were isolated from the cal-
variae of 1-2-day-old ICR mice using a slight modifi-
cation of the method described by Suda et al.
(1997). The calvariae (10–20 of mice) were digest-
ed in 10 ㎖ of α -MEM containing 0.2 % collagenase
(Wako Pure Chemicals, Osaka, Japan) and 0.1% dis-
pase (GIBCO BRL, Grand Island, NY, USA) for 20
min at 37℃ with vigorous shaking, and then cen-
trifuged at 1,500 ×g for 5 min. The first supernatant
was discarded and another 10㎖ of collagenase/dis-
pase enzyme solution were added and incubated
for 20 min. The digestion was repeated four times
and the cells isolated by the last three digestions
were combined as an osteoblastic cell population.
They were cultured in an α-MEM containing 10%
FBS, antibiotics and antimycotics solution (100 U/ml
of penicillin, 100 ㎍/ml of streptomycin, 25 ㎍/ml of
amphotericin B) and used for the assay of ALPase
activity.
4. ALPase activity assays
The isolated calvarial cells were seeded onto 24–
well plates (Nunc, Rochester, NY, USA) at an initial
cell density of 8×105 cells/well. When calvarial cells
reached confluence, the cells were treated with the
sonicates of T. denticola or a combination of soni-
cates and indomethacin in the presence of 10 mM
GP and 50 ㎍/ml AA for 10 days. The medium was
changed every 3 days. The cultured cells were
detached from the plates using an enzyme solution
containing 0.2% collagenase and 0.1% dispase, and
washed twice with PBS. After adding triton X-100
(0.2%, Sigma, St. Louis, MO, USA), the cells were
incubated on ice for 30 min to break the cell mem-
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brane. The lysate was centrifuged at 5,000 ×g for
10 min and the supernatant was used for the ALpase
assay. The ALpase activity in the lysate was mea-
sured by the hydrolysis of p-nitrophenyl phosphate
to p-nitrophenol. An aliquot (20㎕) of the lysate was
mixed with 1㎖ of an ALP-10 solution (Sigma, St.
Louis, MO, USA) and incubated for 2 min at 30℃.
The p-nitrophenol concentration of the mixture was
determined by a spectrophotometer at a wavelength
of 405 nm.
5. Von Kossa staining
The isolated calvarial cells were seeded onto 6 cm
culture dish (Nunc, Rochester, NY, USA) at an initial
cell density of 8 × 105 cells. When calvarial cells
reached confluence, the cells were treated with 10
mM GP and 50 ㎍/ml AA in the absence or pres-
ence of T. denticola sonicates for 21 days. The
medium was changed every 2 days. The formation
of mineralized nodules in cultured cells was mea-
sured by Von Kossa staining as follows. The cells
cultured for 21 days were fixed in 10% formalde-
hyde, stained with silver nitrate, treated with sodium
carbonate formaldehyde and washed with distilled
water. The dishes with mineralized nodules were
photographed.
6. Measurements of PGE2
The cells (8×105 cells/well ) were inoculated
onto 24-well plates. After the cells were grown to
confluence, they were treated with either T. dentico-
la sonicates solely or with a mixture of the sonicates
and indomethacin in the presence of 10 mM GP and
50 ㎍/ml AA for 24 hrs. The medium was changed
every 3 days. The amount of PGE2 in the media and
cells was assessed using commercially available
PGE2 immunoassay system (Amersham Pharmacia
Biotech, Buckinghamshire, England).
7. Cytotoxicity assays 
The calvarial cells were seeded onto 24-well
plates at an initial cell density of 8×105 cells/well
and cultured in α- MEM containing 10 % FBS for 3
days. After various concentrations of T. denticola
sonicates were added to each well, the cells were
cultured for an additional 10 days. The viability of
the cells was determined by a MTT (3-[4,5-
dimethylthiazol-2-yl]- 2,5-diphenyltetrazolium bro-
mide; Sigma, St.Louis, MO, USA) assay. After 10
days of culture, 100 ㎕ of the MTT solution (5㎎/㎖)
was added to each well and incubated for 4 h at 37
℃. The MTT solutions in the wells were removed
and 1 ml of dimethyl sulfoxide was added to dis-
solve the formazan crystals. The optical density of
the formazan solution was measured at 570 nm.
8. Statistical analyses
Statistical differences were determined by the
Mann-Whitney U test. A p value < 0.05 was consid-
ered significant.
III. Results
1. Effects of bacterial sonicates on
ALPase activity and the formation of
mineralized nodules in calvarial cells
The effects of T. denticola sonicates on osteoblast
differentiation were estimated by measuring ALPase
activity and mineralized nodule forming ability of
calvarial cells treated with sonicates. The calvarial
cells were cultured in media supplemented with
either 0.25 or 2.5 ㎍/ml of the sonicates. Inhibition
of ALPase activity and mineralized nodule formation
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was observed in the treated-cells when compared
with the non-treated cells (Figure 1). ALPase activity
was not altered when the calvarial cells were treated
with the heat-denatured T. denticola sonicates (80
℃, 30 min) (Figure 2).
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Figure 1. The inhibitory effects of T. denticola sonicates on osteoblast differentiation.
Confluent calvarial cells grown in 24-well plates were cultured in α-MEM supplemented with 10% FBS and GP/AA for 10 days in the
presence or absence of sonicates (0.25 ㎍/ml, 2.5 ㎍/ml). ALPase activity was measured using p-nitrophenylphosphate as a sub-
strate. Results are expressed as the means ± SE of 4 cultures. * p<0.05 significantly different from non-treated cells (A). Von Kossa
staining of mouse calvarial cells treated with GP/AA for 21 days (B) in the absence (a) or presence (b) of T. denticola sonicates (2.5
㎍/ml). Stained mineralized nodules were seen as small spots.
Figure 2. The inhibitory effects of heat-treated T. denticola sonicates on ALPase activity in mouse calvarial cells.
Confluent calvarial cells grown in 24-well plates were cultured in α-MEM supplemented with 10% FBS and GP/AA for 10 days in the
presence of the sonicates (2.5 ㎍/ml), which were either not heated or heated at 80℃ for 30 min. The ALPase activity was measured
using p-nitrophenylphosphate as a substrate. Results are expressed as the means ± SE of 4 cultures. ** p<0.05 significantly different
from the non-treated cells.
2. Effects of bacterial sonicates on PGE2
production in calvarial cells
The PGE2 production and ALPase activity of the
calvarial cells cultured in the sonicates with/without
indomethacin for 10 days were measured in order to
confirm whether PGE2 was responsible for T. denti-
cola-induced inhibition of ALPase activity. Bacterial
sonicates (2.5 ㎍/ml) caused an increase in PGE2
formation in cells, whereas the non-treated cells
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Figure 3. The effects of T. denticola sonicates on PGE2 formation in mouse calvarial cells.
The cells at confluency were cultured in α-MEM containing 10% FBS and GP/AA or 10% FBS, GP/AA and bacterial sonicates in the
presence or absence of indomethacin for 24 hrs. The PGE2 concentration in the media and cells was analyzed using a PGE2 enzymeim-
munoassay system. Results are expressed as the means ± SE of 4 cultures. * p<0.05 significantly different from non-treated cells.
Figure 4. The effects of indomethacin on the ALPase inhibitory ability of T. denticola sonicates in mouse calvarial cells.
The calvarial cells were cultured to confluence, then treated with GP/AA and the sonicates (2.5 ㎍/ml) in the presence or absence of
indomethacin (1 μM) for 10 days. ALPase activity was estimated using p-nitrophenylphosphate as a substrate. Results are expressed
as the means ± SE of 5 cultures. * p<0.05 significantly different from GP/AA-treated cells.
produced only low levels. Indomethacin (1 μM)
abolished sonicate-induced PGE2 production (Figure
3). However, indomethacin did not affect sonicate-
induced inhibtion of ALPase activity (Figure 4).
3. Effects of bacterial sonicates on cell viability
To determine whether T. denticola could affect
cell viability, the viability of cells cultured in the
presence or absence of sonicates (0.25 and 2.5 ㎍
/ml) for 10 days was compared by a MTT assay. At
concentrations of 0.25 ㎍/ml and 2.5 ㎍/ml, T. den-
ticola sonicates did not affect calvarial cell viability,
when compared with non-treated cells (data not
shown).
IV. Discussion
This report provides the first evidence showing
that T. denticola sonicates inhibited osteoblast differ-
entiation in vitro. In this study we used mouse cal-
varial cells as osteoblastic cells. Rodent calvarial cells
contain a subpopulation of osteoprogenitor cells,
which proliferate and differentiate in osteoblastic
cells and finally form mineralized nodules over the
course of the culture period in the presence of
GP/AA (Nefussi et al., 1985; Aubin et al., 1995). The
stages in osteogenic differentiation correlate with the
bone matrix protein expression in vitro (Lian and
Stein, 1992; Yao et al., 1994). Alkaline phosphatase
(ALP) is expressed early in bone cell differentiation
and is considered to characterize mature osteoblasts
and to be associated with mineralization of the bone
matrix (Yao et al., 1994, Aubin et al., 1995).
Therefore, the effects of T. denticola on osteoblast
differentiation was estimated by the ALPase activity
and the mineralized nodule forming ability of
mouse calvarial cells cultured in the presence of
GP/AA and sonicates of this bacterium. ALPase
activity of GP/AA-treated mouse calvarial cells was
reduced by the presence of T. denticola sonicates
and the inhibition of mineralized nodules formation
was also observed in calvarial cells after treatment
with a combination of GP/AA and sonicates. This
means that T. denticola inhibits osteoblast differenti-
ation.
Porphyromonas gingivalis and Actinobacillus
actinomycetemcomitans have been also implicated
in the etiology of periodontitis (Slots and Ting,
1999). In P. gingivalis, LPS inhibited ALPase activity
in rat calvarial cells (Kadono et al., 1999). In A.
actinomycetemcomitans, it has been demonstrated
that the surface-associated protein (SAP) is a potent
growth inhibitor of the human osteoblast-like cell
line MG63. The characterization of this antiprolifera-
tive activity of SAP demonstrated that it was not
cytotoxic (White et al., 1995). Some groups
(Morimoto et al., 1999; Yamamoto et al., 1999) have
found that the proteinaceous components of A.
actinomycetemcomitans sonicates and its capsular-
like polysaccharide antigen induced apoptotic cell
death in human osteoblastic MG63 cells and mouse
osteoblastic MC3T3–E1 cells, respectively. On the
other hand, it was reported that sonicates of this
bacterium inhibited ALPase activity in MC3T3-E1
cells (Murata et al., 1997).
They showed that the alkaline phosphatase
inhibitory activity occurred at a concentration 100
times lower than the concentration which showed
the apoptosis-inducing property and that the ALPase
inhibitory substance was not a protein. These results
suggest that various bacterial components are
involved in inhibiting osteoblast differentiation by
inducing apoptosis, inhibiting proliferation or
inhibiting the expression of ALPase activity.
Although it has been shown that T. denticola
components, such as the Msp (major surface pro-
tein) and chymotypsin-like protease, have potent
cytotoxic effects on some types of cells (Mathers et
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al. 1996; Fenno et al., 1998), T. denticola sonicates
did not affect the viability of mouse calvarial cells at
a concentration which showed ALPase inhibitory
activity. We have also found that heating the soni-
cates at 80℃ for 30 min prior to addition did not
alter the effect on ALPase activity. These findings
suggest that the inhibition of the osteoblast differen-
tiation was not due to cytotoxicity and that the
inhibitory factor of osteoblast differentiation in the
sonicates was heat-stable. T. denticola contains an
outer membrane lipid, which is chemically close to
lipoteichoic acid, but with properties similar to
lipopolysaccahride (LPS; Schultz et al., 1998;
Ishihara and Okuda, 1999). Although the compo-
nents of T. denticola that mediate the inhibition of
ALPase activity are not known, possible bacterial
components may include a heat-stable LPS like
material.
In vitro studies showed that a higher PGE2 con-
centration suppressed ALPase activity in osteoblastic
MC3T3-E1 cells, while low PGE2 concentrations
stimulated ALPase activity (Suda et al., 1996; Kajii et
al., 1999). In our study, PGE2 biosynthesis in mouse
calvarial cells was enhanced by bacterial sonicates.
Therefore, to examine whether the increased pro-
duction of PGE2 is associated with ALPase inhibitory
ability of the sonicates, the effect of the sonicates on
ALPase activity of cells was observed in the condi-
tion in which the PGE2 response was suppressed.
Indomethacin, an inhibitor of prostagalndin biosyn-
thesis, completely inhibited bacteria-induced PGE2
production. However, treatment of the cells with
this inhibitor did not affect the capacity of the bacte-
rial sonicates to inhibit ALPase activity. This result
demonstrates that the inhibitory effect on ALPase
activity is not linked to bacteria-induced PGE2 pro-
duction.
Physiological bone remodeling is controlled by a
balance between bone formation and resorption.
This balance requires the coupled activities of both
osteoblast and osteoclast. In our previous study
(Choi et al., 1999), at a concentration (2.5 ㎍/ml)
which nhibited the differentiation of osteoblast, T.
denticola sonicates stimulated osteoclast formation,
in part via PGE2. Taken together, these results sug-
gest that T. denticola may be involved in bone
destruction by causing the stimulation of bone
resorption an the inhibition of bone formation. 
In conclusion, our data indicate that sonicates of
T. denticola inhibit osteoblast differentiation. The
inhibition of osteoblast differentiation may be
induced by a PGE2-independent pathway and heat-
stable components of the bacterium may be
involved in osteoblast differentiation. Our results
indicate that T. denticola may play an important role
in bone destruction by inhibiting of bone formation.
V. Conclusion
Periodontal disease is an infectious disorder that
leads to the destruction of alveolar bone.
Treponema (T) denticola is predominant in lesions
of adult periodontitis, but its effects on osteoblasts
have not been reported. 
This study was undertaken to determine the
effects of T. denticola sonicates on the differentia-
tion of osteoblasts.
Osteoblast differentiation was analyzed by the
alkaline phosphatase (ALPase) activity and the for-
mation of mineralized nodules in mouse calvarial
cells. Prostaglandin E2 (PGE2) production in mouse
calvarial cells treated with T. denticola was mea-
sured by an enzyme immunoassay system.
1. T. denticola sonicates (2.5 ㎍/ml) reduced
ALPase activity and the formation of mineral-
ized nodules in mouse calvarial cells. 
2. T. denticola sonicates (2.5 ㎍/ml) increased
PGE2 production of mouse calvarial cells. 
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3. Although indomethacin, an inhibitor of
prostaglandin synthesis, reduced PGE2 produc-
tion in the sonicate-treated cells, it had no effect
on ALPase inhibitory ability of T. denticola.
4. Heating the sonicates did not affect the inhibito-
ry activity on ALPase activity. Taken together,
this study indicates that T. denticola has the
ability to inhibit osteoblast differentiation via a
prostaglandin-independent mechanism. Heat-
stable components of the bacterium may be
involved in the inhibition of osteoblast differen-
tiation. These results suggest that T. denticola
may be involved in the loss of alveolar bone by
decreasing bone formation.
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-국문초록-
Treponema denticola분쇄액에의한조골세포분화억제효과
최봉규1,3, 강정화1, 진승욱1, 옥승호1,3, 이승일1,2,3, 유윤정1,2
연세대학교치과대학구강생물학교실1 및연세대학교치과대학구강과학연구소2, 
연세대학교의과대학BK 의과학사업단3
치주질환은세균감염에의해치조골이파괴되는염증성질환으로서치아상실의주된원인이다.
Treponema denticola는 성인성 치주염의 병소에서 자주 발견되는 세균으로서 부착능 및 단백분해효소생성
능과같은독성인자가밝혀져치주조직파괴에있어서중요성이강조되어왔다. 골개조는조골세포의골형성
및파골세포에의한골흡수의균형에의하여유지되며치주염시야기되는치조골파괴는조골세포및파골세포
기능의불균형에의하여야기되는것으로설명되고있다. 골세포에대한영향으로서 T. denticola는파골세포의
형성을촉진시키는것으로보고되었으나조골세포에대한영향은아직밝혀져있지않다. 따라서 본연구에서
는 T. denticola가 골형성에 미치는 영향을 알아보고자 마우스의 두개골세포로부터 조골세포를 분리한 후 T.
denticola 분쇄액으로처리하여본세균이조골세포의 alkaline phosphatase(ALPase) 활성, 석회화결절형성및
Prostaglandin E2 (PGE2) 생성에 미치는 영향을 평가하였다. ALPase활성은 p-nitrophenylphosphate분해능, 석
회화결절형성은 Von Kossa 염색법, 그리고 PGE2의 농도는 효소면역측정법으로 측정하였다. T. denticola분쇄
액 (2.5 ug/ml)은 마우스두개골세포의 ALPase활성을억제하였으며석회화결절의형성을감소시켰다. 또한 동
일한농도의균분쇄액은마우스두개골세포의 PGE2 생산을증가시켰다. 균분쇄액과 prostaglandin의 합성억제
제인 indomethacin으로 세포를 동시에 처리한 경우 T .denticola분쇄액에 의한 PGE2의 생산은 감소되었으나,
ALPase의 활성억제에는 변화가 없었다. 균분쇄액을 열처리하여 마우스 두개골세포에 처리하였을 때에도
ALPase의 활성이억제되는것에는변함이없었다. 이러한결과는 T. denticola의 구성성분중열에안정한물질
이 prostaglandin과 무관한 경로를 통해 조골세포의 분화를 억제함을 시사하며 이와 같은 T. denticola에 의한
골형성억제가치주염시야기되는치조골파괴에관여할수있을것으로생각된다.
주요어: 치주염, Treponema denticola, 조골세포, 골형성
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